140 related articles for article (PubMed ID: 8232731)
1. [High dose methylprednisolone therapy in patients with multiple sclerosis].
Zakrzewska-Pniewska BZ
Neurol Neurochir Pol; 1993; 27(3):313-9. PubMed ID: 8232731
[TBL] [Abstract][Full Text] [Related]
2. [Evoked potentials with intrathecal and systemic corticosteroid therapy in multiple sclerosis].
Heun R; Emser W; Schimrigk K
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Jun; 20(2):88-91. PubMed ID: 2503359
[TBL] [Abstract][Full Text] [Related]
3. Evoked potentials in multiple sclerosis before and after high-dose methylprednisolone infusion.
Smith T; Zeeberg I; Sjö O
Eur Neurol; 1986; 25(1):67-73. PubMed ID: 3940867
[TBL] [Abstract][Full Text] [Related]
4. Evoked potentials predict the clinical changes in a multiple sclerosis drug study.
Nuwer MR; Packwood JW; Myers LW; Ellison GW
Neurology; 1987 Nov; 37(11):1754-61. PubMed ID: 3313101
[TBL] [Abstract][Full Text] [Related]
5. Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatment.
La Mantia L; Riti F; Milanese C; Salmaggi A; Eoli M; Ciano C; Avanzini G
Ital J Neurol Sci; 1994 Oct; 15(7):333-40. PubMed ID: 7698890
[TBL] [Abstract][Full Text] [Related]
6. Brainstem lesions may be important in the development of epilepsy in multiple sclerosis patients: an evoked potential study.
Papathanasiou ES; Pantzaris M; Myrianthopoulou P; Kkolou E; Papacostas SS
Clin Neurophysiol; 2010 Dec; 121(12):2104-10. PubMed ID: 20542465
[TBL] [Abstract][Full Text] [Related]
7. Inhalational exposure to carbonyl sulfide produces altered brainstem auditory and somatosensory-evoked potentials in Fischer 344N rats.
Herr DW; Graff JE; Moser VC; Crofton KM; Little PB; Morgan DL; Sills RC
Toxicol Sci; 2007 Jan; 95(1):118-35. PubMed ID: 17079700
[TBL] [Abstract][Full Text] [Related]
8. The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis.
Ozkan S; Uzuner N; Kutlu C; Ozbabalik D; Ozdemir G
J Clin Neurosci; 2006 Feb; 13(2):214-7. PubMed ID: 16503485
[TBL] [Abstract][Full Text] [Related]
9. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
Milligan NM; Newcombe R; Compston DA
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):511-6. PubMed ID: 3295122
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic stimulation motor evoked potential in multiple sclerosis. Comparison with visual evoked potentials, brain stem auditory evoked potentials and somatosensory evoked potentials].
Cui L
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Jun; 25(3):130-2, 189. PubMed ID: 1395937
[TBL] [Abstract][Full Text] [Related]
11. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results.
Milanese C; La Mantia L; Salmaggi A; Campi A; Eoli M; Scaioli V; Nespolo A; Corridori F
Eur Neurol; 1989; 29(1):10-4. PubMed ID: 2540005
[TBL] [Abstract][Full Text] [Related]
12. Neurophysiological assessment of auditory, peripheral nerve, somatosensory, and visual system functions after developmental exposure to ethanol vapors.
Boyes WK; Degn LL; Martin SA; Lyke DF; Hamm CW; Herr DW
Neurotoxicol Teratol; 2014; 43():1-10. PubMed ID: 24607749
[TBL] [Abstract][Full Text] [Related]
13. Evoked response study among Malaysian multiple sclerosis patients.
Tan CT; Leong S
Singapore Med J; 1992 Dec; 33(6):575-80. PubMed ID: 1488664
[TBL] [Abstract][Full Text] [Related]
14. Sensory evoked potentials in inhalant (volatile solvent) abuse.
Tenenbein M; Pillay N
J Paediatr Child Health; 1993 Jun; 29(3):206-8. PubMed ID: 8518004
[TBL] [Abstract][Full Text] [Related]
15. [Steroid therapy for multiple sclerosis].
Oishi C; Sakuta M
Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
[TBL] [Abstract][Full Text] [Related]
16. Eye movement quantitative evaluation before and after high-dose 6-methylprednisolone in multiple sclerosis.
Versino M; Bergamaschi R; Callieco R; Romani A; Castelnovo G; Beltrami G; Cosi V
Acta Neurol Scand; 1994 Feb; 89(2):105-10. PubMed ID: 8191872
[TBL] [Abstract][Full Text] [Related]
17. [Value of the studies of multimodal evoked potentials for evaluation of neurotoxic effects of combined exposure to lead, copper and zinc].
Langauer-Lewowicka H; Kazibutowska Z
Neurol Neurochir Pol; 1991; 25(6):715-9. PubMed ID: 1811176
[TBL] [Abstract][Full Text] [Related]
18. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
19. High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. One year follow-up.
Bergamaschi R; Versino M; Raiola E; Citterio A; Cosi V
Acta Neurol (Napoli); 1993 Feb; 15(1):33-43. PubMed ID: 8456594
[TBL] [Abstract][Full Text] [Related]
20. Stimulus-related evoked potentials: from basic science to clinical neuropharmacology.
Sannita WG
Electroencephalogr Clin Neurophysiol Suppl; 1996; 46():95-106. PubMed ID: 9059783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
